Cytokinetics (CYTK) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Cytokinetics (CYTK) over the last 14 years, with Q3 2024 value amounting to 0.0.
- Cytokinetics' Asset Utilization Ratio fell 7884.01% to 0.0 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.0, marking a year-over-year decrease of 7884.01%. This contributed to the annual value of 0.01 for FY2023, which is 9196.56% down from last year.
- Per Cytokinetics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2024, which was down 7884.01% from 0.0 recorded in Q2 2024.
- Over the past 5 years, Cytokinetics' Asset Utilization Ratio peaked at 0.17 during Q2 2022, and registered a low of 0.0 during Q3 2024.
- Over the past 5 years, Cytokinetics' median Asset Utilization Ratio value was 0.07 (recorded in 2021), while the average stood at 0.06.
- Per our database at Business Quant, Cytokinetics' Asset Utilization Ratio tumbled by 9792.32% in 2021 and then soared by 439883.46% in 2022.
- Quarter analysis of 5 years shows Cytokinetics' Asset Utilization Ratio stood at 0.07 in 2020, then decreased by 9.16% to 0.07 in 2021, then skyrocketed by 37.53% to 0.09 in 2022, then plummeted by 89.36% to 0.01 in 2023, then plummeted by 77.4% to 0.0 in 2024.
- Its Asset Utilization Ratio was 0.0 in Q3 2024, compared to 0.0 in Q2 2024 and 0.0 in Q1 2024.